TSHA
#2138
Taysha Gene Therapies, Inc. - Common Stock
6.0 9 USD
+0.07%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+6.84%
Monthly Change
+1.50%
6 month change
+23.53%
Year Change
+141.67%
Previous Close
5.7 0
Open
6.0 1
Low
5.9 4
High
6.1 0
Volume
432
Financials
- Market Capitalization 1.75 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-11.76
Price to sales ratio
187.65
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2128 |  GHRS GH Research PLC - Ordinary Shares | 27.01 USD | +0.90% | +1.16% | +33.32% | +90.75% | 1.68 B USD | ||
| 2136 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 36.66 USD | -3.30% | -2.34% | +31.07% | +92.95% | 1.66 B USD | ||
| 2142 |  ANAB AnaptysBio, Inc. - Common Stock | 56.71 USD | -9.28% | -13.31% | -5.48% | +61.11% | 1.65 B USD | ||
| 2145 |  INVA Innoviva, Inc. - Common Stock | 21.92 USD | +0.83% | -2.84% | -4.57% | +23.01% | 1.62 B USD |
Frequently asked questions about Taysha Gene Therapies, Inc. - Common Stock
What is the Taysha Gene Therapies, Inc. - Common Stock stock price today?
The current price of Taysha Gene Therapies, Inc. - Common Stock (TSHA) is 6.09. Over the past 24 hours, the stock has changed by +6.84%. Follow the TSHA chart for real-time price dynamics.
What is the stock ticker of Taysha Gene Therapies, Inc. - Common Stock?
Taysha Gene Therapies, Inc. - Common Stock trades under the ticker TSHA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Taysha Gene Therapies, Inc. - Common Stock stock going up?
TSHA has changed by -5.14% over the last week, +1.50% over the last month, and +141.67% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Taysha Gene Therapies, Inc. - Common Stock net income for the last quarter?
Taysha Gene Therapies, Inc. - Common Stock reported net income of -42.41 M for the last quarter. The previous quarter showed -27.85 M, which means net income changed by -52.27%.
How many employees does Taysha Gene Therapies, Inc. - Common Stock have?
As of the latest available data, Taysha Gene Therapies, Inc. - Common Stock has 99 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Taysha Gene Therapies, Inc. - Common Stock stock?
You can buy Taysha Gene Therapies, Inc. - Common Stock (TSHA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Taysha Gene Therapies, Inc. - Common Stock stock?
Investing in Taysha Gene Therapies, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TSHA chart and related analysis on metatrader.com as part of your research.